Biliopancreatic diversion with duodenal switch modifies plasma chemerin in early and late post-operative periods

Obesity

Volumn 23, Issue 6, 2015, Pages 1201-1208

  Parlee, Sebastian D ^a   Wang, Yan ^b   Poirier, Paul ^c,d   Lapointe, Marc ^c   Martin, Julie ^c,d,e   Bastien, Marjorie ^c,d   Cianflone, Katherine ^c,d   Goralski, Kerry B ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMERIN; CHEMERIN PROTEIN, HUMAN; CHEMOKINE; SIGNAL PEPTIDE;

ADULT; ANTHROPOMETRY; ARTICLE; BILIOPANCREATIC BYPASS; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CONTROLLED STUDY; FEMALE; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; BARIATRIC SURGERY; BODY MASS; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; OBESITY, MORBID; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; BARIATRIC SURGERY; BILIOPANCREATIC DIVERSION; BODY MASS INDEX; CHEMOKINES; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE PERIOD; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84929952917     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21084     Document Type: Article

References (40)

1. Kelly T, Yang W, Chen CS, Reynolds K, He J,. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008; 32: 1431-1437.
2. Thomas S, Schauer P,. Bariatric surgery and the gut hormone response. Nutr Clin Pract 2010; 25: 175-182.
3. Buchwald H,. A bariatric surgery algorithm. Obes Surg 2002; 12: 733-746; discussion 747-750.
4. Herron DM,. Biliopancreatic diversion with duodenal switch vs. gastric bypass for severe obesity. J Gastrointest Surg 2004; 8: 406-407.
5. Marceau P, Hould FS, Simard S, et al., Biliopancreatic diversion with duodenal switch. World J Surg 1998; 22: 947-954.
6. Pories WJ, Swanson MS, MacDonald KG, et al., Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339-350; discussion 350-332.
7. Schauer PR, Burguera B, Ikramuddin S, et al., Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467-484; discussion 484-465.
8. Buchwald H, Avidor Y, Braunwald E, et al., Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737.
9. Wittamer V, Franssen JD, Vulcano M, et al., Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 2003; 198: 977-985.
10. Zabel BA, Allen SJ, Kulig P, et al., Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J Biol Chem 2005; 280: 34661-34666.
11. Parlee SD, McNeil JO, Muruganandan S, Sinal CJ, Goralski KB,. Elastase and tryptase govern TNFalpha-mediated production of active chemerin by adipocytes. PLoS One 2012; 7: e51072.
12. Cash JL, Hart R, Russ A, et al., Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J Exp Med 2008; 205: 767-775.
13. Goralski KB, McCarthy TC, Hanniman EA, et al., Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 2007; 282: 28175-28188.
14. Zabel BA, Silverio AM, Butcher EC,. Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood. J Immunol 2005; 174: 244-251.
15. Vermi W, Riboldi E, Wittamer V, et al., Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J Exp Med 2005; 201: 509-515.
16. Parolini S, Santoro A, Marcenaro E, et al., The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 2007; 109: 3625-3632.
17. De Palma G, Castellano G, Del Prete A, et al., The possible role of ChemR23/Chemerin axis in the recruitment of dendritic cells in lupus nephritis. Kidney Int 2011; 79: 1228-1235.
18. Rom an AA, Parlee SD, Sinal CJ,. Chemerin: a potential endocrine link between obesity and type 2 diabetes. Endocrine 2012; 42: 243-251.
19. Rourke JL, Dranse HJ, Sinal CJ,. Towards an integrative approach to understanding the role of chemerin in human health and disease. Obes Rev 2013; 14: 245-262.
20. Kralisch S, Weise S, Sommer G, et al., Interleukin-1beta induces the novel adipokine chemerin in adipocytes in vitro. Regul Pept 2009; 154: 102-106.
21. Ernst MC, Issa M, Goralski KB, Sinal CJ,. Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology 2010; 151: 1998-2007.
22. Lehrke M, Becker A, Greif M, et al., Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol 2009; 161: 339-344.
23. Stejskal D, Karpisek M, Hanulova Z, Svestak M,. Chemerin is an independent marker of the metabolic syndrome in a Caucasian population-a pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2008; 152: 217-221.
24. Weigert J, Neumeier M, Wanninger J, et al., Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf) 2010; 72: 342-348.
25. Sell H, Divoux A, Poitou C, et al., Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 2010; 95: 2892-2896.
26. Fatima SS, Bozaoglu K, Rehman R, Alam F, Memon AS,. Elevated chemerin levels in pakistani men: an interrelation with metabolic syndrome phenotypes. PLoS One 2013; 8: e57113.
27. Bozaoglu K, Segal D, Shields KA, et al., Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. J Clin Endocrinol Metab 2009; 94: 3085-3088.
28. Chakaroun R, Raschpichler M, Kloting N, et al., Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism 2011; 61: 706-714.
29. Terra X, Auguet T, Guiu-Jurado E, et al., Long-term changes in leptin, chemerin and ghrelin levels following different bariatric surgery procedures: Roux-en-Y gastric bypass and sleeve gastrectomy. Obes Surg 2013; 23: 1790-1798.
30. Munkonda MN, Martin J, Poirier P, et al., Acylation stimulating protein reduction precedes insulin sensitization after BPD-DS bariatric surgery in severely obese women. Nutr Diabetes 2012; 2: e41.
31. Caron-Cantin SM, Martin J, Bastien M, et al., Acute and chronic effects of biliopancreatic diversion with duodenal switch surgery on plasma visfatin and apelin levels in patients with severe obesity. Obes Surg 2013; 23: 1806-1814.
32. Martin J, Bergeron S, Pibarot P, et al., Impact of bariatric surgery on N-terminal fragment of the prohormone brain natriuretic peptide and left ventricular diastolic function. Can J Cardiol 2013; 29: 969-975.
33. Li Z, Martin J, Poirier P, et al., Upregulation of plasma insulin-like growth factor binding protein 2 levels after biliopancreatic diversion in humans. Obesity (Silver Spring) 2012; 20: 1469-1473.
34. Bozaoglu K, Bolton K, McMillan J, et al., Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007; 148: 4687-4694.
35. Dong B, Ji W, Zhang Y,. Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome. Intern Med 2011; 50: 1093-1097.
36. Yang M, Yang G, Dong J, et al., Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension. J Invest Med 2010; 58: 883-886.
37. Ress C, Tschoner A, Engl J, et al., Effect of bariatric surgery on circulating chemerin levels. Eur J Clin Invest 2010; 40: 277-280.
38. van Herpen NA, Sell H, Eckel J, Schrauwen P, Mensink RP,. Prolonged fasting and the effects on biomarkers of inflammation and on adipokines in healthy lean men. Horm Metab Res 2013; 45: 378-382.
39. Eisinger K, Krautbauer S, Wiest R, Weiss TS, Buechler C,. Reduced serum chemerin in patients with more severe liver cirrhosis. Exp Mol Pathol 2015. http://www.sciencedirect.com/science/article/pii/S001448001500012X?via=ihub.
40. Arita M, Bianchini F, Aliberti J, et al., Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 2005; 201: 713-722.